lanfang du

and 13 more

Aims: To investigate current practices and problems of neurological prognostication in comatose cardiac arrest (CA) patients. Methods: An anonymous questionnaire was distributed to 1600 emergency physicians in 75 hospitals which were selected randomly from China between January and July 2018. Results: 92.1% respondents fulfilled the survey. The details of the neurological prognosis were not well understood. The predictive value of brain stem reflex, motor response and myoclonus was confirmed by 63.5%, 44.6% and 31.7% respondents respectively. Only 30.7% knew that GWR value <1.1 indicated poor prognosis and only 8.1% know the most commonly used SSEP N20. Epileptiform, burst suppression, and isoelectric was considered to predict poor outcome by 35.0%, 27.4% and 45.7% respondents. 46.7% knew NSE, and only 24.7% knew S-100β. Only a few respondents knew that neurological prognostication should be performed later than 72h from CA either in TTM or non-TTM patients. In practice, the most commonly used method was clinical examination (85.4%). 67.9% had used brain CT for prognosis, and 18.4% for MRI. NSE (39.6%) was a little more widely used than S-100β (18.0%). However, SSEP (4.4%) and EEG (11.4%) were occasionally performed. The survey may have been subject to bias ascertainment as only university affiliated hospitals and university teaching hospitals were selected, making it likely that the degree of neuroprognostication awareness and practice reflected in our survey is an optimistic perspective. Conclusions: Neurological prognostication in CA survivors had not been well understood and performed by emergency physicians in China. They were more likely to use clinical examination rather than objective tools, especially SSEP and EEG, which also illustrated that multimodal approach was not well performed in practice.

Junli Liu

and 11 more

Background It has been reported that antibody testing could improve diagnostic efficiency of COVID-19 infection. However the IgM/IgG changes in asymptomatic and discharged patients with reoccurring positive RT-PCR test (RP) remained elusive. Methods 111 patients with positive RT-PCR test and 40 suspected patients were enrolled. We evaluated the diagnostic performance of IgM/ IgG antibodies. Furthermore, the IgM/IgG levels with the disease progress in asymptomatic and RP patients were analyzed. Results Of the 111 RT-PCR positive cases, 17 (15.5%), 42(38.2%), 22 (20%) and 30(27.0%) were categorized into severe, common, mild and asymptomatic group respectively. We find sensitivity and specificity for IgM of 63% and 92.5%, for IgG 77.8 and 95 % respectively. Combining the IgM, IgG and CT we find the best overall performance with95.1 % sensitivity, 75 % specificity. The median IgM and IgG levels were lower in asymptomatic group (IgM0.37, IQR: 0.24-0.78, IgG0.38, IQR: 0.17-1.45) than symptomatic group (IgM1.73, IQR: 0.56-3.74, IgG5.67, IQR: 0.79-18.5) (P < 0.01). All asymptomatic cases were not tracked to infect others. Among 15 RP cases, IgM levels of RP group at the time of discharge (IgM2.79, IQR: 95-5.37) and retest (IgM 2.35, IQR: 0.88-8.65) were significantly higher than those of NRP group (IgM on discharge: 0.59, IQR: 0.33-1.22, IgG on retest: 0.92, IQR: 0.51-1.58). Conclusion Persistent low levels of IgM/IgG in asymptomatic patients may be correlated to less possibility of conversion to symptomatic cases as well as low infectivity. An elevated IgM level may have implications for the identification of RP patients before discharge